Search
News
COVID-19: Joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines
EMA and ECDC have reviewed currently available studies and epidemiological data to provide a common position for EU/EEA countries on the current need and potential benefit of a fourth dose (second booster dose) of mRNA COVID-19 vaccines.
Publication
Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 30 years and older, ECDC multi-country study – second update
This second update contains vaccine effectiveness results among individuals aged 30 years and older, for the pre-Delta and the Delta-dominant periods (3 January–31 May 2021 and 1 July–15 December 2021, respectively).
Publication
COVID-19 vaccine effectiveness in adolescents aged 12–17 years and interim public health considerations for administration of a booster dose
The purpose of this document is to review the evidence of COVID-19 vaccine effectiveness and duration of immunity following vaccination in adolescents aged 12-17 years, and to outline interim public health considerations for the potential use of a booster dose in this group.
Event
Flu Awareness Campaign 2021
The Flu Awareness Campaign is marked across the WHO European Region every year in October. It aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.
News
Early influenza cases indicate the possibility of severe upcoming season for elderly
Although the overall number of influenza detections in the majority of EU/EEA countries is still low, indications show that influenza circulation is above the seasonal threshold in Croatia, which is unusually early. The main reported subtype among the cases recorded in EU/EEA during the past month is A(H3N2), which disproportionally affects older people, and is associated with lower vaccine effectiveness. This is a sign that the upcoming influenza season could be severe for elderly people, and that influenza patterns may vary between countries in terms of timing.
Publication
Core protocol for ECDC studies of COVID-19 vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection laboratory-confirmed with SARS-CoV-2, version 1.0
Core protocol for ECDC studies of COVID-19 vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection laboratory-confirmed with SARS-CoV-2, version 1.0.
News
ECDC builds study infrastructure to monitor COVID-19 vaccine effectiveness
ECDC is creating new infrastructure to allow for regular monitoring and analysis of COVID-19 vaccine effectiveness (VE) over time, using a multi-country approach, through the implementation of studies in different settings.
Event
Flu Awareness Week, 5-9 October 2020
The Flu Awareness Week is marked across the WHO European Region every year in October. It aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.
Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018–2019
Peer-Reviewed Publication
Melidou, A., Hungnes, O., Pereyaslov, D., Adlhoch, C., Segaloff, H., Robesyn, E., Penttinen, P., Olsen, S.J.
Data
Evidence of the efficacy of the HPV vaccines in males
Efficacy/effectiveness, immunogenicity, safety and tolerability of HPV vaccines in males